Instrumento Inactivo

Acciones Algeta ASA Xetra

Acciones

Precio de cierre Xetra Otros sitios de cotización
- ^EUR	-

Actavis : Factbox - M&A frenzy transforming global pharma	06/05/14
Actavis : M&A frenzy in healthcare sector	06/05/14
Algeta ASA : UK cost agency says 'no' to Bayer prostate cancer drug Xofigo	24/03/14
Algeta ASA : Bayer clinches $2.9 billion deal for Norway's Algeta	24/02/14
Bayer AG : Bayer wins cancer firm Algeta with raised $2.9 billion bid	19/12/13

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+20,17 %	126 mil M
REGENERON PHARMACEUTICALS, INC.	+24,67 %	118 mil M
ARGENX SE	+25,44 %	27,87 mil M
BIONTECH SE	-17,74 %	20,95 mil M
GENMAB A/S	-15,17 %	16,92 mil M
BEIGENE, LTD.	-15,21 %	16,18 mil M
NEUROCRINE BIOSCIENCES, INC.	+11,91 %	14,84 mil M
WUXI APPTEC CO., LTD.	-47,10 %	14,79 mil M
SAREPTA THERAPEUTICS, INC.	+54,50 %	14,08 mil M